The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

The first Alzheimer's blood test cleared by the Food and Drug Administration is poised to change the way doctors diagnose and ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the US Food and Drug Administration.

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...

A blood sample analysis can detect markers of this disease at early stages, providing a cheaper and less invasive option for diagnosis. In clinical trials, the Lumipulse blood test was highly ...